APA (7th ed.) Citation

BJ, K., DJ, R., KJ, A., HW, S., M, J., CM, B., . . . S, P. (2021). Development and validation of prescription drug risk, efficacy, and benefit perception measures in the context of direct-to-consumer prescription drug advertising. Research in social & administrative pharmacy : RSAP, 17(5), 942. https://doi.org/10.1016/j.sapharm.2020.07.028

Chicago Style (17th ed.) Citation

BJ, Kelly, et al. "Development and Validation of Prescription Drug Risk, Efficacy, and Benefit Perception Measures in the Context of Direct-to-consumer Prescription Drug Advertising." Research in Social & Administrative Pharmacy : RSAP 17, no. 5 (2021): 942. https://doi.org/10.1016/j.sapharm.2020.07.028.

MLA (9th ed.) Citation

BJ, Kelly, et al. "Development and Validation of Prescription Drug Risk, Efficacy, and Benefit Perception Measures in the Context of Direct-to-consumer Prescription Drug Advertising." Research in Social & Administrative Pharmacy : RSAP, vol. 17, no. 5, 2021, p. 942, https://doi.org/10.1016/j.sapharm.2020.07.028.